News
Merck to donate vaccine doses to IAVI for Sudan ebola virus
The doses will be produced from the existing investigational bulk drug substance previously manufactured by Merck and are intended to be used as part of the World Health Organization’s (WHO’s) efforts to fight the outbreak in Uganda.